| |
| |
|
| Insider
Information: |
Benzeno Sharon |
| Relationship: |
Chief Commercial Ofc I... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
327,415 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,195,065 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
327,415 |
|
|
| Total
Value |
$1,195,065 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adaptive Biotechnologies Corp |
ADPT |
Chief Commercial Ofc I... |
2024-03-05 |
327,415 |
2020-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-05-19 |
4 |
OE |
$1.98 |
$1,351,515 |
D/D |
246,770 |
246,770 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-05-19 |
4 |
AS |
$40.00 |
$9,870,800 |
D/D |
(246,770) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-05-26 |
4 |
OE |
$6.32 |
$2,629 |
D/D |
416 |
416 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-05-26 |
4 |
AS |
$42.00 |
$17,472 |
D/D |
(416) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-06-03 |
4 |
OE |
$6.55 |
$45,468 |
D/D |
6,770 |
6,770 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-06-03 |
4 |
AS |
$40.00 |
$270,800 |
D/D |
(6,770) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-06-19 |
4 |
AS |
$45.00 |
$18,765 |
D/D |
(417) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-06-19 |
4 |
OE |
$6.27 |
$2,615 |
D/D |
417 |
417 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-06-26 |
4 |
OE |
$6.32 |
$2,635 |
D/D |
417 |
417 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-06-26 |
4 |
AS |
$47.42 |
$19,774 |
D/D |
(417) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-07-01 |
4 |
OE |
$6.55 |
$45,475 |
D/D |
6,771 |
6,771 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-07-01 |
4 |
AS |
$47.17 |
$320,540 |
D/D |
(6,771) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-07-20 |
4 |
AS |
$40.00 |
$16,680 |
D/D |
(417) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-07-20 |
4 |
OE |
$6.27 |
$2,615 |
D/D |
417 |
417 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-08-04 |
4 |
OE |
$6.32 |
$48,104 |
D/D |
7,187 |
7,187 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-08-04 |
4 |
AS |
$40.00 |
$287,480 |
D/D |
(7,187) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-08-19 |
4 |
OE |
$6.27 |
$2,608 |
D/D |
416 |
416 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-08-19 |
4 |
AS |
$41.57 |
$17,293 |
D/D |
(416) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-09-01 |
4 |
OE |
$6.55 |
$45,475 |
D/D |
6,771 |
6,771 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-09-01 |
4 |
AS |
$41.28 |
$279,648 |
D/D |
(6,771) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-09-21 |
4 |
AS |
$45.51 |
$18,978 |
D/D |
(417) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-09-21 |
4 |
OE |
$6.27 |
$2,615 |
D/D |
417 |
417 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-10-01 |
4 |
OE |
$6.55 |
$45,475 |
D/D |
6,771 |
6,771 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-10-01 |
4 |
AS |
$48.46 |
$328,837 |
D/D |
(6,771) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-10-19 |
4 |
OE |
$6.27 |
$2,615 |
D/D |
417 |
417 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
